Crossmark

Which bioethical and bio-legal guidelines should be followed when performing pharmacogenetic and pharmacogenomic tests in psychiatry clinical trials in Colombia, to protect genetic data and the rights of research subjects?

Crossref DOI link: https://doi.org/10.1016/j.rcpeng.2018.10.010

Published Print: 2021-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Padrón, Ana Patricia Pacheco

Gil, Felicia Daelé Ramos
License Information

Text and Data Mining valid from 2021-01-01
More Information

This article is maintained by: Elsevier

Article Title: Which bioethical and bio-legal guidelines should be followed when performing pharmacogenetic and pharmacogenomic tests in psychiatry clinical trials in Colombia, to protect genetic data and the rights of research subjects?

Journal Title: Revista Colombiana de Psiquiatría (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rcpeng.2018.10.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rcp.2018.10.005

Content Type: article

Copyright: © 2018 Asociación Colombiana de Psiquiatría. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below